Shilpa Medicare to acquire 30.4% stake in Spain’s Gate2Brain with €7 million investment
Shares of Shilpa Medicare Ltd. are in focus after the company announced a strategic investment in Spain-based biotechnology firm Gate2Brain, marking its latest bet on innovative therapies targeting central nervous system (CNS) disorders and rare cancers. In an exchange filing on Wednesday, Shilpa Medicare said its wholly owned subsidiary, Shilpa Biocare Pvt Ltd, will acquire…
